Shandong Polymer Biochemicals Co., Ltd.

Simbol: 002476.SZ

SHZ

4.61

CNY

Tržna cena danes

  • -1078.4464

    Razmerje P/E

  • 12.5889

    Razmerje PEG

  • 2.82B

    Kapaciteta MRK

  • 0.00%

    Donos DIV

Shandong Polymer Biochemicals Co., Ltd. (002476-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Shandong Polymer Biochemicals Co., Ltd. (002476.SZ). Prihodki podjetja prikazujejo povprečje 563.416 M, ki je 0.057 % gowth. Povprečni bruto dobiček za celotno obdobje je 97.591 M, ki je 0.121 %. Povprečno razmerje bruto dobička je 0.171 %. Rast čistega dobička za lanskoletno poslovanje podjetja je 0.651 %, kar je enako -3.019 % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Shandong Polymer Biochemicals Co., Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini 0.048. Na področju kratkoročnih sredstev 002476.SZ znaša 761.747 v valuti poročanja. Velik del teh sredstev, natančneje 305.577, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za -0.238%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 79.457, če obstajajo, v valuti poročanja. To pomeni razliko v višini 839.498% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 0 v valuti poročanja. Ta številka pomeni medletno spremembo v višini 6.137%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 869.606 v valuti poročanja. Letna sprememba tega vidika je 0.035%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 365.121, zaloge na 84.46, dobro ime pa na 0, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 10.18.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

balance-sheet.row.cash-and-short-term-investments

1259.11305.6401361.8
415.1
442.3
417.8
132.9
91.1
205.6
173.6
285.2
320.7
453
42.4
46.3
14.9

balance-sheet.row.short-term-investments

0.310.30-18.6
-0.7
-1.1
-1.5
-1.4
-0.7
-1.6
-0.6
0
0
0
0
0
0

balance-sheet.row.net-receivables

1010.97365.1248.1127.9
42.3
74.9
178.6
366.1
500.7
512.3
244.4
211.3
240.9
179
92.6
76.9
59.3

balance-sheet.row.inventory

426.5184.58265.7
91.2
91.6
44.9
65.3
104.9
65.5
90.5
98.3
107.8
74.5
33.1
56
124.1

balance-sheet.row.other-current-assets

15.576.624.113.5
16.2
15.5
52.2
71.3
45.2
52.6
168.5
43.5
16
-2.1
-1.8
-2.4
-5.3

balance-sheet.row.total-current-assets

2712.15761.7755.1568.9
564.9
624.3
693.5
635.6
741.9
836
677
638.3
685.4
704.4
166.3
176.8
192.9

balance-sheet.row.property-plant-equipment-net

745.39182.4200.8390
240.2
347.3
477.3
689.2
658.4
409.8
348
342.5
281.8
198.2
201
182.8
157.7

balance-sheet.row.goodwill

0000
0
0
0
0
21
21
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

441.8810.210.711.3
12
37.2
39.6
41.2
24.2
22.2
16.4
18.1
19.8
18.1
14.4
15.4
1.2

balance-sheet.row.goodwill-and-intangible-assets

441.8810.210.711.3
12
37.2
39.6
41.2
45.3
43.3
16.4
18.1
19.8
18.1
14.4
15.4
1.2

balance-sheet.row.long-term-investments

278.3979.58.531.5
15.3
18
27
42.4
45.6
49.3
49.6
0
0
0
0
0
0

balance-sheet.row.tax-assets

20.635.86.57.1
10.9
12
2.7
4.4
2.2
1.8
2.3
1.5
1.6
1.4
1.4
1.1
0.5

balance-sheet.row.other-non-current-assets

24.190.410.81.2
122.1
14.1
35.7
37.1
54.5
25.6
25.6
52.7
0.2
0.3
0
1
0

balance-sheet.row.total-non-current-assets

1510.49278.2237.3441.1
400.4
428.5
582.2
814.3
805.9
529.8
441.8
414.7
303.4
218
216.9
200.3
159.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

4222.641040992.41010.1
965.3
1052.8
1275.7
1449.9
1547.9
1365.8
1118.8
1053
988.8
922.4
383.1
377.1
352.3

balance-sheet.row.account-payables

262.9134.663.158.5
85
98.8
99.9
157
210.2
118.9
86.4
61.1
59
46.8
68.8
51.3
90.3

balance-sheet.row.short-term-debt

60.9111.41.443.1
58.1
30
33.5
54.5
82
60.2
0
0
0
0
80
152.4
100

balance-sheet.row.tax-payables

14.293.23.92.1
0.8
2.8
11.4
20.7
9
14.6
5.3
4.2
-3.4
5.7
5.8
2.5
16.6

balance-sheet.row.long-term-debt-total

000.177.9
8
38
64
42.7
0
0
0
0
0
0
40
0
0

Deferred Revenue Non Current

4.771.31.51.7
2
14.4
14.6
0.9
0.9
0.9
1.2
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0.34---
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

40.6822.8120.5
0.6
30
0.9
0.7
0.2
13.5
28.3
16.2
4.1
12.8
0.7
0.2
11.1

balance-sheet.row.total-non-current-liabilities

5.111.31.779.6
10
173
78.6
178.5
130.3
3.3
1.2
1.8
0
0
40
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

2.31.40.177.9
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

497.51170.4152.4188
156.5
334.6
287.3
414.3
447.2
230.1
116
79.1
63.1
59.6
199.2
210.8
220.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

2448612612612
612
612
612
612
612
612
612
360
180
120
90
90
90

balance-sheet.row.retained-earnings

108.2829.1-0.5-18.5
-31.7
-120.5
149.7
159.8
169.3
169.7
144.9
192.9
156
100.5
76.4
63
31.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

568.6253.553.553.5
53.5
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

349.96175175175
175
226.6
226.6
216.2
234.6
236.4
240
415
589.7
642.3
17.6
13.3
9.8

balance-sheet.row.total-stockholders-equity

3474.86869.6840822
808.8
718.1
988.4
988
1015.9
1018.1
996.9
967.9
925.7
862.8
184
166.3
131.6

balance-sheet.row.total-liabilities-and-stockholders-equity

4222.641040992.41010.1
965.3
1052.8
1275.7
1449.9
1547.9
1365.8
1118.8
1053
988.8
922.4
383.1
377.1
352.3

balance-sheet.row.minority-interest

250.28000
0
0
0
47.6
84.8
117.7
6
5.9
0
0
0
0
0

balance-sheet.row.total-equity

3725.13869.6840822
808.8
718.1
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

4222.64---
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

278.3979.58.512.9
14.5
16.9
25.5
41.1
44.9
47.8
49
52.6
0
0
0
0
0

balance-sheet.row.total-debt

60.9111.41.643.1
66.1
68
97.5
97.2
82
60.2
0
0
0
0
120
152.4
100

balance-sheet.row.net-debt

-1198.2-294.2-399.4-318.8
-349
-374.3
-320.3
-35.7
-9.1
-145.4
-173.6
-285.2
-320.7
-453
77.6
106.2
85.1

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Shandong Polymer Biochemicals Co., Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v -0.724. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 0, kar kaže na razliko 0.000 v primerjavi s prejšnjim letom. Zanimivo je, da je del delnic podjetja, natančneje 0, odkupilo podjetje samo. To dejanje je povzročilo spremembo v 0.000 v primerjavi s prejšnjim letom. Medtem pa obveznosti podjetja trenutno znašajo 10.34 v valuti poročanja. Družba je pri naložbenju porabila neto denarna sredstva v višini -86706693.150 v valuti poročanja. To je premik za -1.726 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 34.89, 0.89 in -9.94, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo -0.41 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane 17.67, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

cash-flows.row.net-income

-2.0729.617.913.2
91.2
-264.1
0.4
-5.4
-9.9
48.3
47
51.2
67.8
56.8
42.8
34.7
25.8

cash-flows.row.depreciation-and-amortization

9.5934.938.840.6
44.7
50.7
40.9
64.2
44.1
41.8
36.1
32.9
23.6
31.1
27.2
26.7
24.9

cash-flows.row.deferred-income-tax

0.690.7-0.23.9
1.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-0.70.2-3.9
-1.1
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-164.92-153.9-101.8-33.6
21.8
15.3
103.3
52.3
34
-191.8
-16.2
85.9
-106.1
-146.9
-1.9
-57.7
-43.2

cash-flows.row.account-receivables

-161.99-162-206.5-52.2
27.5
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-2.92-2.9-15.925.2
0.3
-46.7
20.3
39.7
-37.6
23.2
7.7
9.5
-33.3
-41.5
22.9
68.1
-29.6

cash-flows.row.account-payables

010.3120.9-10.5
-7.2
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00.7-0.23.9
1.1
62
83
12.6
71.6
-215
-23.9
76.4
-72.9
-105.5
-24.9
-125.8
-13.6

cash-flows.row.other-non-cash-items

108.1711.210.212.3
-107.2
250.9
-56.7
34.1
54
-4.7
5
-0.2
5.2
7
13.7
13.5
11.4

cash-flows.row.net-cash-provided-by-operating-activities

104.27000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-11.7-15-19.2-17.7
-10.4
-31.6
-86.7
-116.9
-219.2
-49.3
-45
-122.4
-94.4
-33.9
-28
-42.6
-48.5

cash-flows.row.acquisitions-net

-71.175.5117.52.4
86.9
0
289.9
45.3
0
-39.9
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-40-800.30
0
-10
-30
-38.9
0
0
0
-53.4
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

1.91.922.60
0
0.5
1.4
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-investing-activites

-65.640.9-1.724.1
-143.7
34.7
53.3
-20.2
-26.8
121.8
-120.5
-26.7
-15.8
0.3
0.1
0
0

cash-flows.row.net-cash-used-for-investing-activites

-117.35-86.7119.58.8
-67.2
-6.4
227.9
-130.7
-245.9
32.6
-165.6
-202.4
-110.2
-33.7
-27.9
-42.6
-48.5

cash-flows.row.debt-repayment

-21.82-9.9-30.3-67
-30
-29.5
-47.5
-148.7
-95.2
-67.5
0
0
-50
-264.8
-199.8
-120
-112.8

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-0.57-0.4-5.7-10.4
-4.6
-11.2
-19.8
-25
-22.6
-20
-18
-8.9
-12.6
-34
-10.4
-10.6
-8.1

cash-flows.row.other-financing-activites

24.8117.7-127
28
0
47.8
197
121.2
200.6
0
6
50
795
167.3
172.4
129.4

cash-flows.row.net-cash-used-provided-by-financing-activities

4.157.3-48-70.5
-6.6
-40.7
-19.4
23.4
3.5
113.1
-18
-2.9
-12.6
496.2
-42.9
41.9
8.6

cash-flows.row.effect-of-forex-changes-on-cash

0.91000
0
0
0.1
-2.8
-8.9
-7.2
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

-8.02-157.636.6-29.1
-23.2
5.7
296.6
35
-129.2
32.1
-111.6
-35.5
-132.3
410.6
11
16.6
-21.1

cash-flows.row.cash-at-end-of-period

1184.3240.6398.2361.5
390.7
413.8
408.1
111.5
76.5
205.6
173.6
285.2
320.7
453
42.4
31.4
14.9

cash-flows.row.cash-at-beginning-of-period

1192.32398.2361.5390.7
413.8
408.1
111.5
76.5
205.6
173.6
285.2
320.7
453
42.4
31.4
14.9
35.9

cash-flows.row.operating-cash-flow

104.27-78.2-34.832.5
50.6
52.7
87.9
145.1
122.2
-106.4
71.9
169.8
-9.5
-52
81.8
17.3
18.9

cash-flows.row.capital-expenditure

-11.7-15-19.2-17.7
-10.4
-31.6
-86.7
-116.9
-219.2
-49.3
-45
-122.4
-94.4
-33.9
-28
-42.6
-48.5

cash-flows.row.free-cash-flow

92.56-93.2-5414.9
40.2
21.1
1.2
28.2
-97
-155.7
26.9
47.5
-103.9
-85.9
53.8
-25.3
-29.7

Vrstica izkaza poslovnega izida

Prihodki Shandong Polymer Biochemicals Co., Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za -0.099%. Bruto dobiček podjetja 002476.SZ znaša 129.6. Odhodki iz poslovanja podjetja so 100.83 in so se v primerjavi s prejšnjim letom spremenili za 31.224%. Odhodki za amortizacijo znašajo 34.89, kar je -0.050% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 100.83, ki kaže 31.224% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja 0.216% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so 30.73, ki kažejo 0.216% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je 0.651%. Čisti prihodki v zadnjem letu so znašali 29.63.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

479.79592.3657.2447.3
416.9
449.9
409.8
898
741.6
667.6
685
581.2
542.9
515.4
419.5
542.8
447.4

income-statement-row.row.cost-of-revenue

384.21462.7557.1363.6
365.1
398.9
353.7
725.1
611.7
539.3
568.9
493.5
436
410.2
327.3
457.3
382.7

income-statement-row.row.gross-profit

95.58129.6100.183.7
51.8
51
56.1
172.9
130
128.3
116.1
87.7
106.8
105.2
92.1
85.5
64.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

18.04---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

11.99---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

26.25---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

39.5741.228.919.7
27.2
-121.4
3.5
7.2
23.7
0.7
1.2
2.1
0.8
3.3
1.7
10.9
8.2

income-statement-row.row.operating-expenses

98.38100.876.858.2
74.7
77.3
115.8
149.8
101.8
76.1
58.8
36.6
30.1
27.6
23.9
25.6
13.9

income-statement-row.row.cost-and-expenses

482.59563.5633.9421.9
439.8
476.2
469.5
874.9
713.5
615.5
627.7
530.1
466.1
437.9
351.2
482.9
396.6

income-statement-row.row.interest-income

6.136.75.45.6
7.9
4.4
1.5
0.6
0.4
1.8
3
6.8
7.8
2.2
0.2
0.2
0.1

income-statement-row.row.interest-expense

0.580.54.79.7
4.6
5
1.4
5.2
4.2
1.7
0
0
0.6
6.9
9.8
10.6
8.4

income-statement-row.row.selling-and-marketing-expenses

26.25---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

2.980.3-7.6-9.8
-10.4
-247.1
61.8
-17.1
-24.7
7.8
-0.9
9.6
3.3
-1.7
-10.8
-13.4
-11.5

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

39.5741.228.919.7
27.2
-121.4
3.5
7.2
23.7
0.7
1.2
2.1
0.8
3.3
1.7
10.9
8.2

income-statement-row.row.total-operating-expenses

2.980.3-7.6-9.8
-10.4
-247.1
61.8
-17.1
-24.7
7.8
-0.9
9.6
3.3
-1.7
-10.8
-13.4
-11.5

income-statement-row.row.interest-expense

0.580.54.79.7
4.6
5
1.4
5.2
4.2
1.7
0
0
0.6
6.9
9.8
10.6
8.4

income-statement-row.row.depreciation-and-amortization

-4.0736.938.840.6
44.7
50.7
40.9
64.2
44.1
41.8
36.1
32.9
23.6
31.1
27.2
26.7
24.9

income-statement-row.row.ebitda-caps

-4.59---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-0.5230.725.326.8
102.8
-152
-1.3
-1.1
-20.3
59.2
55.2
58.7
79.2
72.5
57.5
46.7
41.2

income-statement-row.row.income-before-tax

-2.1331.117.717.1
92.4
-273.4
2.1
6
3.4
59.9
56.3
60.8
80.1
75.8
57.5
46.5
39.3

income-statement-row.row.income-tax-expense

-0.071.4-0.23.9
1.1
-9.3
1.7
11.4
13.3
11.6
9.4
9.6
12.3
19
14.6
11.8
13.5

income-statement-row.row.net-income

-2.0729.617.913.2
91.2
-264.1
8.3
14.8
24.1
47.9
46.9
51.2
67.8
56.8
42.8
34.7
25.8

Pogosto zastavljeno vprašanje

Kaj je Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) skupna sredstva?

Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) skupna sredstva so 1039968863.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 212096636.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.199.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 0.151.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je -0.004.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so -0.001.

Kaj je Shandong Polymer Biochemicals Co., Ltd. (002476.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 29630378.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 11381167.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 100833128.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 314019731.000.